Shira Zelber-Sagi

Summary

Affiliation: Rabin Medical Center
Country: Israel

Publications

  1. ncbi Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
    Shira Zelber-Sagi
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel
    World J Gastroenterol 19:57-64. 2013
  2. ncbi Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
    Shira Zelber-Sagi
    Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Israel
    J Hepatol 56:1145-51. 2012
  3. ncbi The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population
    Shira Zelber-Sagi
    Department Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Eur J Gastroenterol Hepatol 24:262-9. 2012
  4. ncbi Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel
    World J Gastroenterol 17:3377-89. 2011
  5. ncbi Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Hepatology 48:1791-8. 2008
  6. ncbi Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study
    Shira Zelber Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel
    J Hepatol 47:711-7. 2007
  7. ncbi Sampling variability of transient elastography according to probe location
    Shira Zelber-Sagi
    Department of Gastroenterology and Liver, Tel Aviv Sourasky Medical Center, Israel
    Eur J Gastroenterol Hepatol 23:507-14. 2011
  8. ncbi Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv, Sourasky Medical Center, Tel-Aviv, Israel
    Liver Int 26:856-63. 2006
  9. ncbi Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis
    Muriel Webb
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 6 Weizman St, Tel Aviv 64239, Israel
    AJR Am J Roentgenol 192:909-14. 2009
  10. ncbi A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Gastroenterol Hepatol 4:639-44. 2006

Collaborators

Detail Information

Publications11

  1. ncbi Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
    Shira Zelber-Sagi
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel
    World J Gastroenterol 19:57-64. 2013
    ..To compare noninvasive methods presently used for steatosis detection and quantification in nonalcoholic fatty liver disease (NAFLD)...
  2. ncbi Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
    Shira Zelber-Sagi
    Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Israel
    J Hepatol 56:1145-51. 2012
    ..This study aims at evaluating NAFLD's epidemiology in prospective follow-up of individuals sampled from the general population...
  3. ncbi The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population
    Shira Zelber-Sagi
    Department Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Eur J Gastroenterol Hepatol 24:262-9. 2012
    ..The aim was to evaluate the association between adipocytokines and presumed liver injury in the general population using noninvasive biomarkers...
  4. ncbi Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel
    World J Gastroenterol 17:3377-89. 2011
    ..Therefore, it is important to identify dietary patterns that will serve as modifiable risk factors for the prevention of NAFLD and its complications...
  5. ncbi Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Hepatology 48:1791-8. 2008
    ..Conclusion: Habitual leisure-time PA, especially anaerobic, may play a protective role in NAFLD. This association appears to be mediated by a reduced rate of abdominal obesity...
  6. ncbi Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study
    Shira Zelber Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel
    J Hepatol 47:711-7. 2007
    ..Weight loss is considered therapeutic for patients with NAFLD. However, there is no epidemiological evidence that dietary habits are associated with NAFLD. Dietary patterns associated with primary NAFLD were investigated...
  7. ncbi Sampling variability of transient elastography according to probe location
    Shira Zelber-Sagi
    Department of Gastroenterology and Liver, Tel Aviv Sourasky Medical Center, Israel
    Eur J Gastroenterol Hepatol 23:507-14. 2011
    ..However, the need for several measurements when using transient elastography was not thoroughly investigated. The aim was to find out whether measurement of liver stiffness varies according to the probe location...
  8. ncbi Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv, Sourasky Medical Center, Tel-Aviv, Israel
    Liver Int 26:856-63. 2006
    ..4, 95% CI 1.3-4.5). CONCLUSIONS: NAFLD is prevalent in the general Israeli population and closely related to the metabolic syndrome. The use of ALT as a marker for NAFLD seriously underestimates its prevalence...
  9. ncbi Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis
    Muriel Webb
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 6 Weizman St, Tel Aviv 64239, Israel
    AJR Am J Roentgenol 192:909-14. 2009
    ..The aim of this study was to assess sonography as an objective tool for the quantification of liver steatosis...
  10. ncbi A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
    Shira Zelber-Sagi
    The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Clin Gastroenterol Hepatol 4:639-44. 2006
    ..4%). There was a statistically significant reversal of fatty liver by US only in the orlistat group (P<.05). CONCLUSIONS: Orlistat improves serum ALT levels and steatosis on US in NAFLD patients, beyond its effect on weight reduction...
  11. ncbi Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation
    Nitsan Maharshak
    Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, 64239 Tel Aviv, Israel
    World J Gastroenterol 17:5007-13. 2011
    ..To examine whether hepatitis C virus (HCV)-infected patients who carry hypercoagulable mutations suffer from increased rates of liver fibrosis...